Citalopram - Therapeutic use
Research News and Information

Saturday, November 21, 2009

Antidepressant medication use during breastfeeding.

30 Aug 2009 We performed an electronic search by using MEDLINE, PreMEDLINE, Current Contents, Biological Abstracts, and PsycINFO from June 2002 to December 2008 using the following terms: "antidepressant drugs", "antidepressive agents", "human milk", ... Read more...

Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients.

30 Aug 2009 OBJECTIVES: Suicidal ideation is an uncommon but worrisome symptom than can emerge during antidepressant treatment. We have described earlier the association between treatment-emergent suicidal ideation (TESI) and markers in genes encoding glutamate ... Read more...

Depressive disorders in stroke patients.

30 Aug 2009 Post-stroke depression is a serious complication of ischemic stroke which has negative influences on patients' quality of life and on recovery from symptoms and the prognosis of the underlying disease. We report here a study of the efficacy of ... Read more...

Latest indexed articles for 'Citalopram - Therapeutic use'

These are the very latest articles for this heading:

• Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. 30 Oct 2009
• Drug fails to subdue repetitive behavior in children with autism spectrum disorders. 29 Sep 2009
• Antidepressant medication use during breastfeeding. 30 Aug 2009
• Genetic studies of drug response and side effects in the STAR*D study, part 2. 30 Aug 2009
• Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. 30 Aug 2009
• Depressive disorders in stroke patients. 30 Aug 2009
• Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. 25 Aug 2009
• Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. 24 Aug 2009
• Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder. 20 Aug 2009
• Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression. 9 Aug 2009
• 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. 3 Aug 2009
• Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression. 30 Jul 2009
• Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study. 30 Jul 2009
• Mean platelet volume in patients with major depression: effect of escitalopram treatment. 30 Jul 2009
• Treatment effects of serotonergic and noradrenergic antidepressants on the intensity dependence of auditory ERP components in major depression. 14 Jul 2009
• Serotonin transporter 5-HTTLPR polymorphism and response to citalopram in terminally ill cancer patients: report of twenty-one cases. 29 Jun 2009
• [Zolpidem dependence and withdrawal seizure] 29 Jun 2009
• Association between depression and survival or disease recurrence in patients with head and neck cancer enrolled in a depression prevention trial. 29 Jun 2009
• Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. 29 Jun 2009
• Diagnosis and treatment of PTSD-related compulsive checking behaviors in veterans of the Iraq war: the influence of military context on the expression of PTSD symptoms. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Citalopram'

Definition: A furancarbonitrile that is one of the SEROTONIN UPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from tardive dyskinesia in preference to tricyclic antidepressants, which aggravate this condition.

Chemical name: 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-

Registry Number: 59729-33-8

Descriptor UI: D015283

Alternative terms: Citalopram; Cytalopram; Lu-10-171; Lu10171; Escitalopram; Lexapro;

Allowable Qualifiers: therapeutic use; toxicity; urine; chemistry; contraindications; agonists; administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution;

Pharmacological Action: Antidepressive Agents, Second-Generation; Serotonin Uptake Inhibitors;

Tree Number: D02.092.831.170; D02.626.320; D03.383.312.225.187; D03.438.127.187;

History Note: 1989; for ESCITALOPRAM use CITALOPRAM (NM) 2001-2002